IDiyas

For the Inventor, By the Inventor

Ingleby Barwick, United Kingdom

Changlin Chen

USPTO Granted Patents = 16 

Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 104(Granted Patents)


Location History:

  • Cleveland, GB (2017 - 2020)
  • Ingleby Barwick, GB (2014 - 2022)

Company Filing History:

goldMedal15 out of 395 
 
Invista North America S.a.r.l.
 patents
silverMedal1 out of 36 
 
Inv Nylon Chemicals Americas, LLC
 patents

Years Active: 2014-2022

Loading Chart...
16 patents (USPTO):Explore Patents
1. 11268110 - Methods and materials for the enzymatic conversion of a non-3-enal to azelaic acid (2022-03-08),
2. 10689673 - Bioconversion process for producing nylon-7, nylon-7,7 and polyesters (2020-06-23),
3. 10577634 - Bioconversion process for producing nylon-7, nylon-7,7 and polyesters (2020-03-03),
4. 10196657 - Methods of producing 7-carbon chemicals via methyl-ester shielded carbon chain elongation (2019-02-05),
5. 9920336 - Methods of producing 7-carbon chemicals from long chain fatty acids via oxidative cleavage (2018-03-20),
6. 9783833 - Biocatalytic methods to convert cyclohexane oxidation process waste streams to useful products (2017-10-10),
7. 9738911 - Methods of producing 7-carbon chemicals via pyruvate and succinate semialdehyde aldol condensation (2017-08-22),
8. 9663801 - Methods of producing four carbon molecules (2017-05-30),
9. 9650653 - Bioconversion process for producing nylon-7, nylon-7,7 and polyesters (2017-05-16),
10. 9637764 - Methods of producing 7-carbon chemicals via carbon chain elongation associated with cyclohexane carboxylate synthesis (2017-05-02),
11. 9617572 - Methods of producing 7-carbon chemicals via aromatic compounds (2017-04-11),
12. 9580731 - Methods of producing 7-carbon chemicals via c1 carbon chain elongation associated with coenzyme B synthesis (2017-02-28),
13. 9422580 - Methods for biosynthesizing 1,3 butadiene (2016-08-23),
14. 9422578 - Methods for biosynthesizing 1,3 butadiene (2016-08-23),
15. 9334508 - Methods of producing carboxylic acids (2016-05-10),

Title: Innovations of Changlin Chen in Biochemical Engineering

Introduction

Changlin Chen, located in Ingleby Barwick, GB, is a distinguished inventor with a remarkable portfolio of 16 patents. His innovative contributions primarily focus on biochemical processes and materials, particularly involving the enzymatic conversion of compounds for various applications in biotechnology and materials science.

Latest Patents

Changlin Chen's latest patents encompass significant advancements in biochemical pathways for converting non-3-enal to azelaic acid. His patent details methods using polypeptides with hydroperoxide lyase activity to produce crucial intermediates like pimeloyl-CoA, which can be transformed into various valuable compounds such as pimelic acid and heptamethylenediamine. Additionally, he has developed a bioconversion process aimed at producing nylon-7 and polyesters via the biosynthesis of di- or trifunctional C7 alkanes using isolated enzymes or recombinant host cells expressing specific enzymatic activities.

Career Highlights

Over the course of his career, Changlin Chen has made significant contributions while working with industry leaders like Invista North America S.a.r.l. and Inv Nylon Chemicals Americas, LLC. His work at these companies has played a crucial role in advancing the field of biochemical engineering, focusing on sustainable and efficient production processes.

Collaborations

Changlin Chen has collaborated with notable professionals in his field, including Paul S. Pearlman and Alex Van Eck Conradie. These partnerships have facilitated the exchange of ideas and fostered innovative approaches to complex biochemical challenges.

Conclusion

Changlin Chen’s inventive spirit and dedication to advancing biochemical processes showcase his significant contributions to science and industry. His patents reflect a commitment to innovation that addresses both contemporary challenges and future opportunities in the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…